Fluorine-18-Labeled Diaryl-azines as Improved β-Amyloid Imaging Tracers: From Bench to First-in-Human Studies
Authors:
- 18 March 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 66 (7) , 4603-4616
Abstract
The deposition of β-amyloid (Aβ) in the brain is a pathologic hallmark of Alzheimer's disease (AD), appearing years before the onset of symptoms, and its detection is incorporated into clinical diagnosis. Here, we have discovered and developed a class of diaryl-azine derivatives for detecting Aβ plaques in the AD brain using PET imaging. After a set of comprehensive preclinical assessments, we screened out a promising Aβ-PET tracer, [18F]92, with a high binding affinity to the Aβ aggregates, significant binding ability with the AD brain sections, and optimal brain pharmacokinetic properties in rodents and non-human primates. The first-in-human PET study declared that [18F]92 displayed low white matter uptake and could bind to Aβ pathology for distinguishing AD from healthy control subjects. All these results support that [18F]92 might become a promising PET tracer for visualizing Aβ pathology in AD patients.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2021ZD0201103, 2021ZD0201803)
- National Natural Science Foundation of China (22022601, U1967221)
This publication has 50 references indexed in Scilit:
- Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-Amyloid Imaging in Aging and DementiaJournal of Nuclear Medicine, 2013
- Development of Positron Emission Tomography β-Amyloid Plaque Imaging AgentsSeminars in Nuclear Medicine, 2012
- Novel 18F-Labeled Benzofuran Derivatives with Improved Properties for Positron Emission Tomography (PET) Imaging of β-Amyloid Plaques in Alzheimer’s BrainsJournal of Medicinal Chemistry, 2011
- In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)Journal of Nuclear Medicine, 2010
- 18F Stilbenes and Styrylpyridines for PET Imaging of Aβ Plaques in Alzheimer’s Disease: A MiniperspectiveJournal of Medicinal Chemistry, 2009
- PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosisBrain, 2007
- 18F-labeled styrylpyridines as PET agents for amyloid plaque imagingNuclear Medicine and Biology, 2007
- Fluoro-pegylated (FPEG) Imaging Agents Targeting Aβ AggregatesBioconjugate Chemistry, 2006
- Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathologyEMBO Reports, 2006
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004